Dengzhanxixin Injection for Acute Ischemic Stroke Receiving Reperfusion Therapy

Clinical trial NCT05700097 · UNKNOWN

Trial details

NCT number: NCT05700097
Sponsor: Beijing Tiantan Hospital
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Acute Ischemic Stroke

Start date: 2022-09-30
Primary completion: 2023-09-30
Enrollment: 240

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.